Insider Trading activities of Spring Bank Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Spring Bank Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Spring Bank Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Spring Bank Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is SBPH. The reporting company's CIK number is 1566373.
The total value of stock buying since 2005 is $2,158,767.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Spring Bank Pharmaceuticals, Inc. (SBPH).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 1,000 $14,840 0 $0 0 $0
2017-08 4,500 $55,322 0 $0 0 $0
2017-06 76,923 $999,999 0 $0 0 $0
2017-02 1,200 $10,515 0 $0 0 $0
2016-12 2,000 $17,000 0 $0 0 $0
2016-11 11,000 $94,470 0 $0 0 $0
2016-09 6,400 $79,250 0 $0 0 $0
2016-08 21,500 $237,379 0 $0 0 $0
2016-05 54,166 $649,992 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Spring Bank Pharmaceuticals, Inc. insiders (SBPH)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-14 Driscoll Martin J (President and CEO) Buy 1,000 14.84 14,840
2017-08-04 Arkowitz David (Director) Buy 2,500 12.24 30,612
2017-08-03 Driscoll Martin J (President and CEO) Buy 2,000 12.36 24,710
2017-06-27 Eichler Kurt M (Director) Buy 76,923 13.00 999,999
2017-02-23 Eichler Kurt M (Director) Buy 1,200 8.76 10,515
2016-12-15 Driscoll Martin J (President and CEO) Buy 2,000 8.50 17,000
2016-11-30 Driscoll Martin J (President and CEO) Buy 2,000 7.98 15,960
2016-11-09 Eichler Kurt M (Director) Buy 7,000 8.69 60,830
2016-11-09 Driscoll Martin J (President and CEO) Buy 2,000 8.84 17,680
2016-09-19 Eichler Kurt M (Director) Buy 1,346 12.50 16,825
2016-09-16 Eichler Kurt M (Director) Buy 650 12.50 8,125
2016-09-14 Eichler Kurt M (Director) Buy 514 12.50 6,425
2016-09-13 Eichler Kurt M (Director) Buy 490 12.50 6,125
2016-09-09 Afdhal Nezam H. (Chief Medical Officer) Buy 2,400 12.50 30,000
2016-09-02 Driscoll Martin J (President and CEO) Buy 1,000 11.75 11,750
2016-08-30 Driscoll Martin J (President and CEO) Buy 1,000 12.41 12,410
2016-08-24 Afdhal Nezam H. (Chief Medical Officer) Buy 2,000 11.96 23,926
2016-08-23 Freve Jonathan (CFO, Treasurer & Secretary) Buy 1,000 10.74 10,740
2016-08-23 Eichler Kurt M (Director) Buy 3,000 10.73 32,190
2016-08-22 Driscoll Martin J (President and CEO) Buy 1,000 11.66 11,660
2016-08-19 Driscoll Martin J (President and CEO) Buy 1,000 11.20 11,200
2016-08-16 Afdhal Nezam H. (Chief Medical Officer) Buy 100 11.49 1,149
2016-08-16 Driscoll Martin J (President and CEO) Buy 1,000 11.37 11,370
2016-08-15 Afdhal Nezam H. (Chief Medical Officer) Buy 1,800 11.43 20,574
2016-08-15 Driscoll Martin J (President and CEO) Buy 1,000 11.20 11,200
2016-08-12 Afdhal Nezam H. (Chief Medical Officer) Buy 2,600 11.33 29,450
2016-08-09 Driscoll Martin J (President and CEO) Buy 2,000 11.03 22,050
2016-08-04 Freve Jonathan (CFO, Treasurer & Secretary) Buy 1,000 9.75 9,750
2016-08-04 Eichler Kurt M (Director) Buy 1,000 9.79 9,790
2016-08-04 Driscoll Martin J (President and CEO) Buy 2,000 9.96 19,920
2016-05-11 Eichler Kurt M (Director) Buy 41,666 12.00 499,992
2016-05-11 Driscoll Martin J (President and CEO) Buy 12,500 12.00 150,000

Insider trading activities including stock purchases, stock sales, and option exercises of SBPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Spring Bank Pharmaceuticals, Inc. (symbol SBPH, CIK number 1566373) see the Securities and Exchange Commission (SEC) website.